Omada Health (OMDA) vs Tyra Biosciences, Inc. (TYRA)

A side-by-side comparison of Omada Health and Tyra Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — OMDA vs TYRA

growth of $100 · dividends reinvested · last 1y
OMDA -8.9% (-8.9%/yr)TYRA +105.8% (+105.8%/yr)TYRA compounded faster over this window
100200300400Start $1002026$91$206
OMDA TYRA

OMDA vs TYRA: by the numbers

  • •OMDA is the larger company ($1.23B vs $1.21B market cap).
  • •OMDA is profitable (1.39% net margin) while TYRA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricOMDATYRA
P/E ratio329.05N/A
P/S ratio3.98N/A
P/B ratio4.883.41
EV / EBITDA145.65N/A
FCF yield1.63%N/A

Profitability

MetricOMDATYRA
Gross margin68.19%0.00%
Operating margin-0.15%0.00%
Net margin1.39%0.00%
ROE1.70%-42.01%
ROIC-0.18%-44.73%

Growth (annualized)

MetricOMDATYRA
Total return CAGR (5Y)N/A9.23%

Frequently asked

Is OMDA or TYRA more profitable?
OMDA runs the higher net margin — OMDA at 1.39% versus TYRA at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.